- Home
- MGTX vs OFIX Comparison
MGTX vs OFIX Comparison
Compare MGTX & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGTX | OFIX |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.9M | 637.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MGTX | OFIX |
|---|---|---|
| Price | $8.57 | $15.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $23.83 | $21.50 |
| AVG Volume (30 Days) | ★ 706.5K | 240.7K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $27,417,000.00 | ★ $818,058,000.00 |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | $619.95 | $5.84 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 96.83 | 4.31 |
| 52 Week Low | $4.55 | $10.24 |
| 52 Week High | $9.73 | $20.48 |
Technical Indicators
Market Signals| Indicator | MGTX | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 57.48 | 56.76 |
| Support Level | $7.60 | $15.58 |
| Resistance Level | $8.34 | $16.23 |
| Average True Range (ATR) | 0.51 | 0.64 |
| MACD | 0.06 | 0.08 |
| Stochastic Oscillator | 91.81 | 76.87 |
Price Performance
Historical ComparisonAbout MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.